ARCHIVES

Pryce Introduces Bill To Reimbuse For Orally Administered Cancer Drugs.

This article is from The Cancer Letter archive.

Vol. 27 No. 18 | May 4, 2001

Download PDF Visit The Full Archive

Related Articles

FDA Ceases Exclusion Of Women From Early Drug Studies

May 7, 1993

New Approaches To Therapy For Difficult Cancers Presented

June 29, 2007

NCI Advisors Reject $30-Million Cohort Study, Approve Renewal of Phase I Clinical Trials Initiatives and American College of Radiology Imaging Network.

July 7, 2006

Shubik Warns NCA Members They May Be Prober’s Next Target

May 22, 1981

Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial.

March 1, 2002

DCT Planning To Stop Use Monkeys In Preclinical Test

November 17, 1978